Development of a Flow Cytometric Co-Immunoprecipitation Technique for the Study of Multiple Protein-Protein Interactions and Its Application to T-Cell Receptor Analysis

被引:11
|
作者
Bridgeman, John S.
Blaylock, Morgan [2 ]
Hawkins, Robert E.
Gilham, David E. [1 ]
机构
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Canc Res UK Dept Med Oncol,Cell Therapy Grp, Paterson Inst Canc Res,Sch Canc & Imaging Sci, Wilmslow Rd, Manchester M20 4BX, Lancs, England
[2] Univ Manchester, Flow Cytometry Grp, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England
基金
英国生物技术与生命科学研究理事会;
关键词
T-cell receptor; CD3; zeta; co-immunoprecipitation; protein-protein interactions; ANTIGEN RECEPTOR; CD3-ZETA CHAIN; ZETA-CHAIN; COMPLEX; ASSAY; SYNTHESIZE; FAILURE;
D O I
10.1002/cyto.a.20840
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Co-immunoprecipitation is the classical approach for investigating protein protein interactions. Analysis is generally conducted using the Western blot approach. We set out to investigate whether flow cytometry was a feasible alternative to Western blotting. Using the TCR-CD3 complex as a model for intermolecular interactions in the MA5.8 cell line, FLAG-tagged CD3 zeta-scFv fusion proteins could be captured on anti-FLAG coupled beads and associated TCR beta molecules could be detected by flow cytometry. This association was abrogated by mutations to the CD3 zeta transmembrane domain. Using multicolor flow cytometry, TCR beta, CD3 epsilon, and the scFv region of the CD3 zeta fusion molecule could all be detected from a single sample. This multicolor analysis was then applied to demonstrate the importance of correct lysis conditions for extraction of the TCR complex. In summary, this flow cytometric immunoprecipitation technique is a feasible alternative to classical co-immunoprecipitation analysis technique and offers many potential advantages including rapid analysis with increased target sensitivity, reduced technical demands, amenable to multiple protein analysis from a single sample, and provides a framework that may facilitate the development of high throughput analytical assays investigating protein protein interactions. (C) 2009 International Society for Advancement of Cytometry
引用
收藏
页码:338 / 346
页数:9
相关论文
共 10 条
  • [1] Co-immunoprecipitation and semi-quantitative immunoblotting for the analysis of protein-protein interactions
    Burckhardt, Christoph J.
    Minna, John D.
    Danuser, Gaudenz
    STAR PROTOCOLS, 2021, 2 (03):
  • [2] An optimized co-immunoprecipitation protocol for the analysis of endogenous protein-protein interactions in cell lines using mass spectrometry
    Lagundzin, Dragana
    Krieger, Kimiko L.
    Law, Henry C. -H.
    Woods, Nicholas T.
    STAR PROTOCOLS, 2022, 3 (01):
  • [3] Quantitative Phosphoproteomic Analysis of T Cell Receptor Signaling Reveals System-Wide Modulation of Protein-Protein Interactions
    Mayya, Viveka
    Lundgren, Deborah H.
    Hwang, Sun-Il
    Rezaul, Karim
    Wu, Linfeng
    Eng, Jimmy K.
    Rodionov, Vladimir
    Han, David K.
    SCIENCE SIGNALING, 2009, 2 (84) : ra46
  • [4] FLOW CYTOMETRIC ANALYSIS OF PROTEIN-TYROSINE PHOSPHORYLATION IN PERIPHERAL T-CELL SUBSETS - APPLICATION TO HEALTHY AND HIV-SEROPOSITIVE SUBJECTS
    VUILLIER, F
    SCOTTALGARA, D
    CAYOTA, A
    SICILIANO, J
    NUGEYRE, MT
    DIGHIERO, G
    JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 185 (01) : 43 - 56
  • [5] Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sezary syndrome using T-cell receptor Vβ chain antibodies and its application in blood staging
    Feng, Bo
    Jorgensen, Jeffrey L.
    Jones, Dan
    Chen, Su S.
    Hu, Ying
    Medeiros, L. Jeffrey
    Wang, Sa A.
    MODERN PATHOLOGY, 2010, 23 (02) : 284 - 295
  • [6] Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
    Jurgens, Eric M.
    Firestone, Ross S.
    Chaudhari, Jagrutiben
    Hosszu, Kinga
    Devlin, Sean M.
    Shah, Urvi A.
    Landa, Jonathan
    Mcavoy, Devin P.
    Lesokhin, Alexander M.
    Korde, Neha
    Hassoun, Hani
    Tan, Carlyn R.
    Hultcrantz, Malin
    Shah, Gunjan L.
    Landau, Heather J.
    Chung, David J.
    Scordo, Michael
    Eren, Ozgur Can
    Dogan, Ahmet
    Giralt, Sergio A.
    Park, Jae H.
    Riviere, Isabelle
    Brentjens, Renier J.
    Smith, Eric L.
    Wang, Xiuyan
    Usmani, Saad Z.
    Mailankody, Sham
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (05)
  • [7] Comparison of T-cell immune responses to SARS-CoV-2 spike (S) and nucleocapsid (N) protein using an in-house flow-cytometric assay in laboratory employees with and without previously confirmed COVID-19 in South Africa: nationwide cross-sectional study
    van Rooyen, Cathrine
    Brauer, Marieke
    Swanepoel, Petri
    van den Berg, Sylvia
    van der Merwe, Cassandre
    van der Merwe, Marischa
    Green, Robin
    Becker, Piet
    JOURNAL OF CLINICAL PATHOLOGY, 2023, 76 (06) : 384 - 390
  • [8] Phase I Trial of MCARH109, a First-in-Class G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted CAR T-cell Therapy for Relapsed or Refractory Multiple Myeloma: Updated Analysis
    Jurgens, Eric
    Firestone, Ross
    Chaudhari, Jagrutiben
    Hosszu, Kinga
    Devlin, Sean
    Shah, Urvi
    Landa, Jonathan
    McAvoy, Devin
    Lesokhin, Alexander
    Korde, Neha
    Hassoun, Hani
    Tan, Carlyn
    Hultcrantz, Malin
    Shah, Gunjan
    Landau, Heather
    Chung, David
    Scordo, Michael
    Dogan, Ahmet
    Giralt, Sergio
    Riviere, Isabelle
    Brentjens, Renier
    Smith, Eric
    Wang, Xiuyan
    Usmani, Saad
    Mailankody, Sham
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S62 - S63
  • [9] BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor ( CAR) T-Cell Therapy for Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 Study
    Bal, Susan
    Htut, Myo
    Nadeem, Omar
    Larry, Anderson D., Jr.
    Kocoglu, Hakan
    Gregory, Tara
    Rossi, Adriana C.
    Martin, Tom
    Egan, Daniel N.
    Costa, Luciano
    Hu, Hongxiang
    Chen, Yanping
    Li, Shaoyi
    Kelly, Lisa M.
    Sarkis, Naomey
    Ziyad, Safiyyah
    Kao, Wei-Ming
    Kaeding, Allison June
    Burgess, Michael R.
    Berdeja, Jesus G.
    BLOOD, 2023, 142
  • [10] BMS-986393 (CC-95266), a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted CAR T-cell therapy for relapsed/refractory multiple myeloma (RRMM): results from a phase 1 study
    Nadeem, Omar
    Berdeja, Jesus
    Htut, Myo
    Kocoglu, M. Hakan
    Gregory, Tara
    Anderson, Larry
    Rossi, Adriana
    Egan, Daniel
    Costa, Luciano
    Kelly, Lisa
    Ziyad, Safiyyah
    Hu, Hongxiang
    Chen, Yanping
    Kaeding, Allison
    Burgess, Michael
    Bal, Susan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S54 - S55